Abstract
The xeroderma pigmentosum (XP) population in the UK is around 100 patients. Since 2010, their medical care has been provided by a single national multidisciplinary clinical service, which cares for patients of all ages.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
Beck AT, Steer RA, Brown GK. Manual for the Beck depression inventory-II. San Antonio, TX: The Psychological Corporation; 1996.
Broadbent E, et al. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–7.
WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551–8.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Randolph C. Repeatable battery for the assessment of neuropsychological status manual. San Antonio, TX: The Psychological Corporation; 1998.
Fassihi H, et al. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect. Proc Natl Acad Sci U S A. 2016;113(9):E1236–45.
Sethi M, et al. A distinct genotype of XP complementation group A: surprisingly mild phenotype highly prevalent in northern India/Pakistan/Afghanistan. J Invest Dermatol. 2016;136(4):869–72.
Sethi M, et al. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions. Br J Dermatol. 2013;169(6):1279–87.
Kondo S, et al. Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F. Photo-Dermatology. 1989;6(2):89–95.
Nishigori C, Fujisawa H, Uyeno K, Kawaguchi T, Takebe H. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage. Photodermatol Photoimmunol Photomed. 1991;8(4):146–50.
Schafer A, et al. Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription. J Invest Dermatol. 2013;133(7):1841–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Fassihi, H., Garrood, I., Chandler, N., Mohammed, S., Lehmann, A.R., Sarkany, R. (2019). Xeroderma Pigmentosum in the UK. In: Nishigori, C., Sugasawa, K. (eds) DNA Repair Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-10-6722-8_8
Download citation
DOI: https://doi.org/10.1007/978-981-10-6722-8_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-6721-1
Online ISBN: 978-981-10-6722-8
eBook Packages: MedicineMedicine (R0)